Dupilumab improves clinical outcome assessments in children with eosinophilic esophagitis in a randomized phase 3 study.

Chehade M, Spergel JM, Oliva S, Dellon ES, Ashok D, Rothenberg ME, Liu R, Louisias M, Radin A, Tilton ST, McCann E

DOI: 10.1186/s12876-026-05017-8
Published: 2026 Jul 29
Container: BMC gastroenterology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12876-026-05017-8,
  title = {Dupilumab improves clinical outcome assessments in children with eosinophilic esophagitis in a randomized phase 3 study.},
  author = {Chehade M and Spergel JM and Oliva S and Dellon ES and Ashok D and Rothenberg ME and Liu R and Louisias M and Radin A and Tilton ST and McCann E},
  year = {2026},
  journal = {BMC gastroenterology},
  doi = {10.1186/s12876-026-05017-8},
  url = {https://doi.org/10.1186/s12876-026-05017-8}
}

RIS

TY  - JOUR
TI  - Dupilumab improves clinical outcome assessments in children with eosinophilic esophagitis in a randomized phase 3 study.
AU  - Chehade M
AU  - Spergel JM
AU  - Oliva S
AU  - Dellon ES
AU  - Ashok D
AU  - Rothenberg ME
AU  - Liu R
AU  - Louisias M
AU  - Radin A
AU  - Tilton ST
AU  - McCann E
PY  - 2026
JO  - BMC gastroenterology
DO  - 10.1186/s12876-026-05017-8
UR  - https://doi.org/10.1186/s12876-026-05017-8
ER  -

APA

M, C., JM, S., S, O., ES, D., D, A., ME, R., R, L., M, L., A, R., ST, T., & E, M. (2026). Dupilumab improves clinical outcome assessments in children with eosinophilic esophagitis in a randomized phase 3 study.. BMC gastroenterology. https://doi.org/10.1186/s12876-026-05017-8

Source records

pubmed · retrieved 2026-11-10T13:32:20.280Z
europe-pmc · retrieved 2026-11-10T13:32:20.283Z